Desensitization therapy combined with budesonide/symbicort inhalant for treatment of allergic bronchial asthma
10.3760/cma.j.issn.1008-6706.2013.19.007
- VernacularTitle:脱敏疗法联合布地奈德/福莫特罗粉吸入剂治疗过敏性支气管哮喘疗效观察
- Author:
Xuxin BAO
;
Yuexiang SHUI
- Publication Type:Journal Article
- Keywords:
Asthma;
Desensitization therapy;
Symbicort
- From:
Chinese Journal of Primary Medicine and Pharmacy
2013;20(19):2895-2897
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the desensitization therapy combined with budesonide/symbicort inhalant for treatment of allergic bronchial asthma.Methods 80 patients with allergic asthma randomly divided into observation group and control group,each group of 40 cases.Two groups were given conventional treatment and desensitization therapy,the control group required glucocorticoid,the observation group received budesonide/symbicort inhalant.were evaluated.Results The total effective rate in the observation group was 92.5％ (37/40),the control group was 72.5％(29/40),the difference was statistically significant (P ＜0.05).FEV1.0％ in the two groups after treatment,PET and symptom score were significantly improved after treatment(P ＜0.05).The observation group improved more significantly than that of the control group (P ＜0.05).The incidence of adverse reaction in observation group was 15％(6/40),significantly less than that in the control group 35％ (14/40),the difference was statistically significant (P ＜0.05).Conclusion Desensitization therapy combined with budesonide/symbicort inhalant in asthma symptoms could improve asthma and lung function,which has high safety and worthy of clinical application.
